Melody Chang, RPh, MBA, BCOP

Panelists discuss how the successful management of iron deficiency anemia requires a comprehensive approach combining early detection, appropriate choice of iron formulation, careful monitoring of treatment response, and addressing barriers to care while emphasizing the importance of patient education and […]

Video content above is prompted by the following: How can future initiatives improve patient education and awareness about IDA? What impact could this have on early detection and treatment adherence? How do you envision the future advancements in the treatment

Video content above is prompted by the following: Adherence to recommended treatment dosing tends to decline as the number of separate recommended infusion visits increases. Could you share your clinical experience on how variations in dosing among different agents influence

Video content above is prompted by the following: How has the recent increase in step edits for high-dose IV iron injections impacted your practice? How can providers still ensure access to high-dose IV iron formulations? Source link Melody Chang, RPh,

Panelists discuss how iron deficiency anemia significantly impacts patients’ quality of life through symptoms like chronic fatigue, shortness of breath, and cognitive dysfunction, while also creating substantial psychosocial burdens including depression, reduced work productivity, and social isolation, particularly affecting vulnerable

Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, and reduced erythropoietin synthesis, resulting in both functional and absolute iron deficiency alongside diminished